Log In
Contact Us
  • Blog
  • About Us
    • Who We Are
    • PRIM&R Partners
    • Resources
    • Ampersand Blog
    • Career Center
  • Conference
    • Annual Conference
    • Exhibit
    • Past Conferences
  • Certification
    • Eligibility
    • Certification Exams
    • CIP and CPIA Councils
    • CIP and CPIA Recertification
  • Programs
    • Education at PRIM&R
    • Flash Learn
    • Workshops
    • Seminars
    • Symposium
    • Courses
    • Webinars
    • Certificates
  • Membership
    • Member Benefits
    • Member Hub
  • Understanding Research
    • Research Ethics Timeline
    • Lead the Way
    • Research Ethics Reimagined Podcast
    • People and Perspectives
  • Public Policy
    • Research Ethics in Public Policy
    • Advocacy Toolkit
    • Resources
    • Policy Comments
  • Support Us
    • Donate
    • Volunteer
    • Sponsor
    • Bookstore
  • Policies
    • PRIM&R Policy
    • Events Code of Conduct
    • Reporting Misconduct

Public Policy Take Action

Tell Congress: Public Safety Depends on the Integrity of Research Oversight

PRIM&R is committed to protecting the integrity of research, which is why we joined a growing national coalition, led by Research!America, to urge a bipartisan group of U.S. House of Representatives and U.S Senate Appropriations Committee leaders to “prioritize robust funding for the National Institutes of Health (NIH) in the Fiscal Year 2025 appropriations bill.” The letter included legislative language that would prevent the administration from moving forward with changes to indirect cost reimbursement (15% indirect cost cap) at the NIH, which would reduce NIH funding by billions of dollars, if implemented, and would have immediate and harmful consequences. The coalition letter to Congress made clear:
“The Administration’s proposed policy to drastically reduce NIH funding by at least $4 billion would have immediate and harmful consequences—slowing scientific progress, delaying treatments and cures, and weakening the U.S. research ecosystem. NIH funding is a key driver of economic growth, job creation, and medical breakthroughs, and this policy change would hinder our ability to remain globally competitive.
We must maintain the integrity of research oversight, and that requires congressional support for adequate funding. Cutting funds weakens ethical frameworks and can hinder scientific progress and delay the availability of crucial therapies and cures, directly jeopardizing public health.”
Full NIH Community Sign On Letter

Your Voice Matters.

Join us in contacting Congress to emphasize that public safety relies on strong research oversight and robust NIH funding. Efforts to reduce NIH funding threaten an effective oversight process and undermine ethical scientific research. We cannot stand by while important research and scientific integrity is threatened.

Let Your Voice Be Heard.

Can You Take 5 Minutes Today to Call Your Members of Congress?

Use the Congressional Directory to contact your officials to advocate for sustained NIH funding and research integrity to protect public health.

Find Your Elected Officials

Use the Congressional Directory for quick and easy access. Enter your address to identify your members of Congress.
Directory

What To Say

When reaching out, keep your message clear, concise, and impactful.
🔹 We must maintain the integrity of research oversight, and that requires congressional support for adequate funding. 🔹 Make clear that cuts to NIH funding would harm scientific progress and public health. This means delaying the discovery of new treatments, preventing medical progress, and undermining our country's ability to tackle current and future health challenges. This is a public safety issue. 🔹 Call upon Congress to fight for nonpartisan, evidence-based research policies.

Upcoming Events

Federal Public Policy Briefing | Wednesday, April 2 | 9:30–10:15 AM ET This briefing will provide updates, and an opportunity to ask questions, about federal policy developments and their implications for research oversight. Speakers: Holly Fernandez Lynch, JD, MBE, a PRIM&R Board Member and Associate Professor of Medical Ethics at University of Pennsylvania Carrie D. Wolinetz, PhD, Principal and Chair of Lewis-Burke Associates LLC’s Health and Bioscience Innovation Policy Practice Group
Register Here

Additional Resources

PRIM&R's Public Policy Work
Latest Policy Updates
Find Your Legislator
Contact UsLogin
About Us
Who We Are
PRIM&R Partners
Career Center
Space
Conference
Annual Conference
Past Conferences
Space
space
Certification
Eligibility
Certification Exams
Recertification
Certification Councils
PRIM&R Membership
PRIM&R Member Benefits
Member Hub
Space
Donate
Volunteer
Sponsor
Space
Space
Terms and Conditions
Privacy Policy
PRIM&R Policy
Cookie Policy
Copyright © 2025 PRIM&R. All rights reserved.

We use cookies to enable essential functionality on our website, and analyze website traffic. By clicking Accept you consent to our use of cookies. Read about how we use cookies.

Your Cookie Settings

We use cookies to enable essential functionality on our website, and analyze website traffic. Read about how we use cookies.

Cookie Categories
Essential

These cookies are strictly necessary to provide you with services available through our websites. You cannot refuse these cookies without impacting how our websites function. You can block or delete them by changing your browser settings, as described under the heading "Managing cookies" in the Privacy and Cookies Policy.

Analytics

These cookies collect information that is used in aggregate form to help us understand how our websites are being used or how effective our marketing campaigns are.